His primary areas of study are Internal medicine, Genetics, Endocrinology, Kidney disease and Diabetes mellitus. His Internal medicine research includes elements of Gastroenterology, Nephropathy and Type 2 diabetes. His study in Single-nucleotide polymorphism, Genome-wide association study, Genetic association, Linkage disequilibrium and Genetic predisposition is done as part of Genetics.
His study in Single-nucleotide polymorphism is interdisciplinary in nature, drawing from both Allele frequency and Haplotype. His studies deal with areas such as Nephrology, Renal function, Case-control study, Apolipoprotein L1 and Kidney as well as Kidney disease. Barry I. Freedman has researched Diabetes mellitus in several fields, including Pedigree chart and Risk factor.
Barry I. Freedman mostly deals with Internal medicine, Diabetes mellitus, Genetics, Endocrinology and Kidney disease. His Internal medicine research is multidisciplinary, relying on both Nephropathy, Type 2 diabetes and Cardiology. His research integrates issues of Odds ratio, Diabetic nephropathy, Immunology and End stage renal disease in his study of Nephropathy.
His studies examine the connections between Diabetes mellitus and genetics, as well as such issues in Proportional hazards model, with regards to Hazard ratio. His Kidney disease research integrates issues from Nephrology, Bioinformatics, Gastroenterology, Pathology and Kidney. His Single-nucleotide polymorphism study combines topics from a wide range of disciplines, such as Case-control study and Allele frequency.
His primary scientific interests are in Internal medicine, Kidney disease, Genome-wide association study, Genetics and Diabetes mellitus. His Internal medicine study often links to related topics such as Cardiology. His Kidney disease study integrates concerns from other disciplines, such as Gastroenterology, Apolipoprotein L1, Nephropathy, Urinary system and Disease.
His Genome-wide association study research incorporates elements of SNP, Polymorphism, Genetic association and Medical genetics. His work focuses on many connections between Genetics and other disciplines, such as Cholesterol, that overlap with his field of interest in Lipid metabolism. His Diabetes mellitus research is under the purview of Endocrinology.
Barry I. Freedman mainly focuses on Genome-wide association study, Internal medicine, Genetics, Allele and Locus. The subject of his Genome-wide association study research is within the realm of Single-nucleotide polymorphism. He combines subjects such as Diabetes mellitus, Type 2 diabetes and Cardiology with his study of Internal medicine.
A large part of his Genetics studies is devoted to SNP. His research in SNP intersects with topics in Vitamin D and neurology and Endocrinology. The Kidney disease study combines topics in areas such as Nephropathy, Stroke, Lupus nephritis, Disease and Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human polymorphism at microRNAs and microRNA target sites.
Liuqing Yang;Chunru Lin;Chunyu Jin;Joy C. Yang.
Frontiers in Genetics (2013)
A genome-wide association search for type 2 diabetes genes in African Americans.
N D Palmer;C W McDonough;P J Hicks;B H Roh.
PLOS ONE (2012)
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Giulio Genovese;Giulio Genovese;David J. Friedman;Michael D. Ross;Laurence Lecordier.
The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility
Enrique Gonzalez;Hemant Kulkarni;Hector Bolivar;Andrea Mangano.
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
Mary F. Feitosa;Aldi T. Kraja;Daniel I. Chasman;Yun J. Sung.
PLOS ONE (2018)
The genetic architecture of type 2 diabetes
Christian Fuchsberger;Christian Fuchsberger;Jason A. Flannick;Jason A. Flannick;Tanya M. Teslovich;Anubha Mahajan.
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
Jeffrey B Kopp;Michael W Smith;George W Nelson;Randall C Johnson.
Nature Genetics (2008)
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
W H Linda Kao;Michael J Klag;Lucy A Meoni;David Reich;David Reich.
Nature Genetics (2008)
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Afshin Parsa;W. H Linda Kao;Dawei Xie;Brad C. Astor.
The New England Journal of Medicine (2013)
Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy
W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler.
American Journal of Nephrology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: